ATEYX
Price
$164.53
Change
+$1.47 (+0.90%)
Updated
Jan 22 closing price
Net Assets
1.79B
NPFCX
Price
$60.26
Change
+$0.31 (+0.52%)
Updated
Jan 22 closing price
Net Assets
146.92B
Ad is loading...

ATEYX vs NPFCX

Header iconATEYX vs NPFCX Comparison
Open Charts ATEYX vs NPFCXBanner chart's image
AB Sustainable Global Thematic Advisor
Price$164.53
Change+$1.47 (+0.90%)
VolumeN/A
Net Assets1.79B
American Funds New Perspective C
Price$60.26
Change+$0.31 (+0.52%)
VolumeN/A
Net Assets146.92B
ATEYX vs NPFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ATEYX vs. NPFCX commentary
Jan 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATEYX is a Buy and NPFCX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 147B vs. ATEYX (1.79B). ATEYX pays higher dividends than NPFCX: ATEYX (0.22) vs NPFCX (0.20). ATEYX was incepted earlier than NPFCX: ATEYX (28 years) vs NPFCX (24 years). ATEYX is a more actively managed with annual turnover of: 42.00 vs. NPFCX (17.00). ATEYX has a lower initial minimum investment than NPFCX: ATEYX (0) vs NPFCX (250). NPFCX annual gain was more profitable for investors over the last year : 15.26 vs. ATEYX (4.33). NPFCX return over 5 years is better than : 30.44 vs. ATEYX (22.46).
ATEYXNPFCXATEYX / NPFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years24 years-
Gain YTD4.9034.076120%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.79B147B1%
Annual Yield % from dividends0.220.20109%
Returns for 1 year4.3315.2628%
Returns for 3 years-1.585.84-27%
Returns for 5 years22.4630.4474%
Returns for 10 years92.7869.40134%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTCR1.690.07
+4.32%
Heartcore Enterprises
PEBO32.200.85
+2.71%
Peoples Bancorp
CLVT5.440.08
+1.49%
Clarivate Plc
CRDF3.540.02
+0.57%
Cardiff Oncology
CQP60.51-2.28
-3.63%
Cheniere Energy Partners LP